# A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)

> **NCT02130362** · — · ACTIVE_NOT_RECRUITING · sponsor: **AbbVie** · enrollment: 1446 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02130362
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2014-08-28
- **Primary completion:** 2030-11
- **Final completion:** 2030-11
- **Target enrollment:** 1446 (ACTUAL)
- **Last updated:** 2025-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02130362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02130362, "A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02130362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*